Menu
Mediacenter
Interactive & Videos
Play Video
EACTS | 2019 | Lisbon | Symposium
1/9 videos
1
Enhanced hemodynamic and metabolic stability in aortic surgery | EACTS | 2019 | Lisbon |
14:20
2
Improved clinical outcome in ECMO patients | EACTS | 2019 | Lisbon |
18:29
3
Intraoperative use in endocarditis -The REMOVE trial | EACTS | 2019 | Lisbon |
17:20
4
Faster control of refractory vasoplegic shock | Nandor Marczin | EACTS 2019
22:45
5
6
Effects on outcome in mitral valve infective endocarditis | Daniel Wendt | EACTS 2019
15:26
7
Reduction of inflammation in heart transplantation | Endre Németh | EACTS | 2019 | Lisbon
17:27
8
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019
20:12
9
Removal of Ticagrelor during emergency heart surgery and reduction of complications and costs
20:12
ESICM Lives 2019 | Berlin
1/5 videos
1
Improved outcome of patients in septic shock | ESICM Lives 2019: Webcast
24:20
2
Advantages of CytoSorb compared to other liver support systems | ESICM Lives 2019: Webcast
21:27
3
What makes it unique Rationale of CytoSorb | ESICM Lives 2019: Webcast
20:10
4
Drug removal and safety aspects – what do we currently know | ESICM Lives 2019: Webcast
18:01
5
Improved outcome of patients in septic shock | ESICM Lives 2019: Summary
01:53
Sepsis Update 2019 | Weimar | Symposium Webcast
1/4 videos
1
Hemodynamic changes during hemoadsorption – Which parameters matter | Sepsis Update 2019
18:06
2
Timing and dosing as part of an individualized therapy in septic shock | Sepsis Update 2019
16:04
3
How we use CytoSorb in clinical routine | Sepsis Update 2019
11:24
4
What makes it unique? Rationale and background of CytoSorb Therapy | Sepsis Update 2019
14:22
TCS ECMO 2019 | Paris | Symposium Webcast
1/2 videos
1
TCS ECMO 2019 | Paris | Webcast Pappalardo
11:53
2
TCS ECMO 2019 | Paris | Webcast Traeger
27:23
6th International CytoSorb Users` Meeting | 2019 | Brussels
1/10 videos
1
Welcome - 6th International CytoSorb Users` Meeting
09:06
2
My very special CytoSorb case
11:16
3
My clinical experiences after 100 patients
11:48
4
From experiments to evidence: Safety aspects and drug removal
46:58
5
Hemoadsorption modulates pulmonary metabolism and edema formation
11:56
6
CytoSorb in cardiac arrest
11:08
7
CytoScore helps me to find the right starting point
10:26
8
Opening Lecture: Past, present and future of CytoSorb
30:36
9
CytoSorb in various fields of application: Liver failure
15:04
10
What do we know and what do we have to do? CytoSorb in various fields of application: ECMO
11:34
EACTS | 2018 | Milan | Symposium Webcast
1/5 videos
1
MOF in ECMO patients and the impact of CytoSorb therapy – 3 years’ experience
09:19
2
Improved outcome of patients undergoing heart transplant with CytoSorb | EACTS | 2018 | Milan
09:34
3
Clinical effects of intraoperative hemoadsorption in acute infective endocarditis – A case series
10:57
4
5
Intraoperative removal of Ticagrelor to reduce bleeding complications... | EACTS | 2018 | Milan
09:13
Application of Cytosorb
1/6 videos
1
Hemoperfusion set up for stand alone application of CytoSorb
02:09
2
CytoSorb ECMO Integration - English - Animation
03:36
3
CTSO Application PreDialzer
02:57
4
CTSO Application PostDialzer
03:09
5
CTSO Application CPB
02:33
6
CTSO Application exchange
02:16
CytoSorb Testimonials
1/6 videos
1
Future – What do you think about the future of CytoSorb?
01:56
2
Early use – When should CytoSorb be started in septic shock?
01:15
3
Safety – How would you describe the safety profile of CytoSorb?
46
4
Ease of use – How easy is the set-up of CytoSorb?
01:05
5
Clinical effects – What are the most impressive clinical effects when you use CytoSorb?
04:37
6
CytoSorb Testimonials
03:30
Disclaimer
The statements here represent the personal opinions and views of the speaker only and do not necessarily reflect accepted medical knowledge in general or indications covered by the intended use of CytoSorb. CytoSorb must be used by health care professionals only.